Society of Hematologic Oncology Sixth Annual Meeting
Avatar

Next Questions in Myeloma: Biology, Smoldering Myeloma, High-risk, MRD, and How to Salvage Therapy

By Society of Hematologic Oncology Sixth Annual Meeting FEATURING Sundar Jagannath
10/2018
0 Comments
Login to view comments. Click here to Login

Featured Video

10:17
Amgen Oncology

Multiple Myeloma: Use of Proteasome Inhibitor at First Relapse-A Case Study

Feat. H. Kaya

Featured Video

10:17
Amgen Oncology

Multiple Myeloma: Use of Proteasome Inhibitor at First Relapse-A Case Study

Feat. H. Kaya

Related Content

AUTOPLAY
Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

Wed, Sep 11, 2019
Eurasian Hematology-Oncology Group

Xth Eurasian Hematology-Oncology Congress

Tue, Oct 8, 2019
25:51
The University of Kansas Cancer Center

MM - Overview of Trials Presented at ASH 2018

Feat. A. Abdallah
06:12
Indy Hematology Review

Targeting Mutations in Myeloma with Venetoclax and Development of the Fi...

Feat. K. Anderson
17:03
Ajai Chari

Diagnosing Smoldering Multiple Myeloma

19:49
Gareth J Morgan

Contemporary Design of MM Treatment: Developing New Therapeutic Endpoint...

05:05
Indy Hematology Review

Risk of Progression of Smoldering Myeloma to Active Multiple Myeloma

Feat. K. Anderson
08:15
2018 Pan Pacific Lymphoma Conference

Evolution of Myeloma Induction Regimens

Feat. S. Holstein
15:02
Krina Patel

Clinical Trials in Myeloma in 2018

16:22
Society of Hematologic Oncology Sixth Annual Meeting

FDA Approves Selinexor for Refractory Multiple Myeloma, STORM Study

Feat. S. Jagannath
09:49
Nina Shah

Maximizing the Initial Gains in Myeloma Therapy: Consolidation and Maint...

19:41
Peter Voorhees

Approach to the Patient with Refractory & Multiple Relapsed Multiple Mye...

17:17
Society of Hematologic Oncology Sixth Annual Meeting

Emerging Data on Management and Imaging of Myeloma Bone Disease

Feat. M. Dimopoulos
15:11
Ajay Nooka

Early Relapse: Choosing Among Different Second Line Regimens in Myeloma

13:26
Shaji Kumar

Evolving Concepts in the Diagnosis and Risk Stratification of Myeloma

21:40
Natalie Callander

Smoldering Myeloma: Risk Stratification and Therapeutic Options

17:02
Thomas Martin

Novel Clinical Trials for Smoldering Multiple Myeloma in 2018

12:32
Indy Hematology Review

What's New in Immunotherapy and Genomics in Multiple Myeloma?

Feat. K. Anderson
15:10
Krina Patel

Developing CAR T-cells in Multiple Myeloma

15:47
Society of Hematologic Oncology Sixth Annual Meeting

Myeloma State of the Art Update: Bone Disease, MRD Assessment, How to Ma...

Feat. S. Lonial
09:01
Maria-Victoria Mateos

FDA Approves Once-Weekly Carfilzomib Regimen for Myeloma

15:31
Parameswaran Hari

Refractory and Relapsing Myeloma - When to Treat and Options Available